BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 10, 2014
View Archived Issues
New mouse model of ulcerative colitis developed to investigate the ileal epithelial barrier
Read More
TNI BioTech forms new subsidiary, Cytocom
Read More
Amarantus acquires option to license intellectual property for MANF and CDNF
Read More
Takeda files for Japanese approval of trelagliptin succinate for type 2 diabetes
Read More
Valneva signs cell-line agreement with Emergent BioSolutions for vaccine development
Read More
Tamoxifen found to have potential in treating spinal cord injury
Read More
Arena Pharmaceuticals reports discovery of H3 receptor antagonists
Read More
Galapagos earns partial milestone payment under osteoarthritis alliance with Servier
Read More
Cancer Therapeutics CRC discloses new VEGFR-3 inhibitors for cancer
Read More
Yissum Research Development synthesizes cytotoxic vanadium and titanium complexes
Read More
AiCuris patents new RT inhibitors for HIV infection
Read More
Bayer patent divulges novel BRD4 inhibitors
Read More
Bayer Group completes takeover offer for Algeta
Read More
Interim phase III data show BPL factor X is well tolerated in patients with hereditary FX deficiency
Read More
Sirturo obtains conditional approval in the E.U. for multidrug-resistant tuberculosis
Read More
Digital Aria signs agreement to develop RegeneRx's RGN-259 and RGN-137
Read More
Independent committee recommends continuation of phase III trial of algenpantucel-L
Read More
MolMed requests conditional marketing authorization for TK therapy in the E.U.
Read More
Fibrotech completes phase Ia study of FT-011 for diabetic nephropathy
Read More
Torii reports results from domestic study of TO-203 for house dust mite-induced allergic rhinitis
Read More
Transition from pdFIX to newly developed rFIX, BAX-326, is safe and clinically effective
Read More
New grant supports ThromboGenics' research in DME
Read More
C3 Jian begins phase II study of C-16G2 for prevention of dental caries
Read More
Researchers develop a novel 7-microRNA hematologic cancer panel
Read More
Phase IIb/III trial of EPI-743 begins in Leigh syndrome
Read More
Cytox initiates clinical trials of mTOR blood tests for dementia
Read More